Loading organizations...
Medicis Capital GmbH operates as an investment and advisory firm, specializing in strategic guidance and private equity investments within the healthcare sector. The firm focuses on medical technologies, molecular diagnostics, specialty pharmaceuticals, and healthcare delivery services, offering expertise in transactional and operational support for mid-sized companies and innovative ventures.
Medicis Capital GmbH was founded in Munich in 1994. Its inception was driven by the specialized requirements for both capital and strategic counsel within the evolving healthcare industry. Professor Dr. Kai Deusch, a habilitated physician with extensive experience, is recognized as the Founder, Owner, and CEO of the Medicis Group of Companies, including Medicis Capital GmbH, leveraging his deep industry knowledge to establish the firm's focused approach.
The firm’s clientele comprises companies and investors navigating the complexities of the healthcare landscape, whom it assists through tailored financial strategies and industry insights. Medicis Capital aims to catalyze growth and innovation across the life sciences and healthcare markets, fostering the development of crucial medical advancements and supporting its partners in achieving long-term strategic objectives.
Medicis Capital has 2 tracked investments across 2 companies. The latest tracked deal is $33.0M Series D in MyoScience in March 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 21, 2012 | MyoScience | $33.0M Series D | — | Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Nexus Medical Partners, Saratoga Ventures, Valiance |
| Jan 8, 2010 | Kiora Pharmaceuticals | $22.6M Series D | — | Emerging Capital Partners, Innoven Partners, Natixis, Ventech |